Raises FY26 revenue view to $312M-$314M from $308M-$313M, consensus $310.27M. Raises FY26 adjusted EBITDA view to $8M-$10M from $6M-$10M.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANGO:
- Options Volatility and Implied Earnings Moves This Week, January 06 – January 08, 2026
- ANGO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Midday Fly By: Tesla reports deliveries, Trump delays furniture tariff hike
- Buy Rating for AngioDynamics Driven by New Clinical Trial and Product Synergy
- AngioDynamics Announces Board Election at Annual Meeting